Leslie B Rall

Title: Leslie B Rall: Innovator in Insulin-like Growth Factors

Introduction

Leslie B Rall is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the area of insulin-like growth factors. Her work has implications for medical research and therapeutic applications.

Latest Patents

Leslie B Rall holds a patent for "Prepro insulin-like growth factors I and II." This patent includes polynucleotide sequences that encode for human prepro insulin-like growth factors. These sequences are derived from the human genome, typically obtained by screening a cDNA library from human liver cells. The polynucleotide sequences can be utilized for cloning and expression of insulin-like growth factors in suitable hosts. Additionally, they can be used for the production of DNA and RNA for hybridization probes. Notably, E. coli strains HB101(phigf1) and HB101(phigf2) were deposited at the ATCC on June 8, 1984, and were granted accession numbers 39729 and 39730, respectively.

Career Highlights

Leslie B Rall has had a distinguished career, working with Chiron Corporation, where she has been able to apply her innovative ideas in a practical setting. Her research has contributed to advancements in biotechnology and has opened new avenues for medical treatments.

Collaborations

Throughout her career, Leslie has collaborated with notable colleagues, including Graeme Ian Bell and James P Merryweather. These collaborations have further enhanced her research and development efforts in the field.

Conclusion

Leslie B Rall is a trailblazer in the field of insulin-like growth factors, with a patent that showcases her innovative spirit and dedication to advancing biotechnology. Her work continues to influence the medical research landscape.